Abstract
Semisynthetic derivatives of natural products traditionally occupy a prominent space in natural-product-based drug discovery (1, 2). As many biologically active natural products exhibit a high degree of structural complexity (3), the chemical derivatization of material isolated from natural sources often represents the only feasible means (or at least the only economically viable approach) to explore structure-activity-relationships (SAR) and to produce analogs with more favorable pharmacokinetic and pharmacological properties than the natural product lead. Examples of clinically important drugs that are semisynthetic derivatives of natural products exist in virtually all disease areas (1, 2); in the treatment of cancer this includes compounds such as etoposide or teniposide (derived from podophyllotoxin) (4–6), irinotecan and topotecan (derived from camptothecin) (7–9), or docetaxel (derived from 10-deacetylbaccatin III) (10, 11). Even for taxol (11), which is a natural product (12), the sustained supply of sufficient quantities of material for widespread clinical use could only be secured through the development of a semisynthetic production process from another natural product, namely, 10-deacetylbaccatin III (13). In light of these facts, it is not surprising that semisynthesis approaches have also featured prominently in the elucidation of the SAR for epothilones and in the discovery of a number of clinical development candidates.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Butler MS (2004) The Role of Natural Product Chemistry in Drug Discovery. J Nat Prod 67: 2141
Hamann MT (2003) Enhancing Marine Natural Product Structural Diversity and Bioactivity Through Semisynthesis and Biocatalysis. Curr Pharm Design 9: 879
Henkel T, Brunne RM, Müller H, Reichel F (1999) Statistical Investigation into the Structural Complementarity of Natural Products and Synthetic Compounds. Angew Chem Int Ed 38: 643
Kuhn M, Keller-Juslén C, von Wartburg A (1969) Mitosis-inhibiting Natural Substances. XXII. Partial Synthesis of 4′-Demethylepipodophyllotoxin. Helv Chim Acta 52: 944
Keller-Juslén C, Kuhn M, von Wartburg A, Stähelin H (1971) Mitosis-inhibiting Natural Products. 24. Synthesis and Antimitotic Activity of Glycosidic Lignan Derivatives Related to Podophyllotoxin. J Med Chem 14: 936
You Y (2005) Podophyllotoxin Derivatives: Current Synthetic Approaches for New Anticancer Agents. Curr Pharm Design 11: 1695
Sawada S, Yokokura T, Miyasaka T (1995) Synthesis and Antitumor Activity of A-ring or E-lactone Modified Water-Soluble Prodrugs of (20S)-Camptothecin, Including Development of Irinotecan Hydrochloride Trihydrate (CPT-11). Curr Pharm Design 1: 113
Kingsbury WD, Boehm JC, Jakas DR, Holden KG, Hecht SM, Gallagher G, Caranfa MJ, McCabe FL, Faucette L, Johnson RK, Hertzberg RP (1991) Synthesis of Water-Soluble (Aminoalkyl) Camptothecin Analogs: Inhibition of Topoisomerase I and Antitumor Activity. J Med Chem 34: 98
Mathijssen RHJ, Loos WJ, Verweij J, Sparreboom A (2002) Pharmacology of Topoisomerase I Inhibitors Irinotecan (CPT-11) and Topotecan. Curr Cancer Drug Targets 2: 103
Guenard D, Gueritte-Voegelein F, Potier P (1993) Taxol and Taxotere: Discovery, Chemistry, and Structure-activity Relationships. Acc Chem Res 26: 160
Rowinsky EK (1997) The Development and Clinical Utility of the Taxane Class of Antimicrotubule Chemotherapy Agents. Ann Rev Med 48: 35
Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant Antitumor Agents. VI. Isolation and Structure of Taxol, a Novel Antileukemic and Antitumor Agent from Taxus brevifolia. J Am Chem Soc 93: 2325
Holton RA, Biediger RJ, Boatman D (1995) Semisynthesis of Taxol and Taxotere. In: Suffness M (ed.) Taxol: Science and Applications, p. 97. CRC, Boca Raton, FL
Höfle G, Reichenbach H (2005) Epothilone, a Myxobacterial Metabolite with Promising Antitumor Activity. In: Cragg GM, Kingston DGI, Newman DJ (eds.) Anticancer Agents from Natural Products, p. 413. Taylor & Francis, Boca Raton, FL
Arslanian RL, Tang L, Blough S, Ma W, Qiu R-G, Katz L, Carney JR (2002) A New Cytotoxic Epothilone from Modified Polyketide Synthases Heterologously Expressed in Myxococcus xanthus. J Nat Prod 65: 106
Niggemann J, Michaelis K, Frank R, Zander N, Höfle G (2002) Natural Product-derived Building Blocks for Combinatorial Synthesis. Part 1. Fragmentation of Natural Products from Myxobacteria. JCS Perkin Trans: 2490
Borzilleri RM, Zheng X, Schmidt RJ, Johnson JA, Kim SH, DiMarco JD, Fairchild CR, Gougoutas JZ, Lee FYF, Long BH, Vite GD (2000) A Novel Application of a Pd(0)-Catalyzed Nucleophilic Substitution Reaction to the Regio-and Stereoselective Synthesis of Lactam Analogues of the Epothilone Natural Products. J Am Chem Soc 122: 8890
Vite GD, Borzilleri RM, Kim SH, Regueiro-Ren A, Humphreys WG, Lee FYF (2001) Epothilones A and B: Springboards for Semisynthesis of Promising Antimitotic Agents. In: Ojima I, Vite GD, Altmann K-H (eds.) Anticancer Agents—Frontiers in Cancer Chemotherapy. ACS Symposium series 796. p. 148. American Chemical Society, Washington DC
Regueiro-Ren A, Leavitt K, Kim SH, Höfle G, Kiffe M, Gougoutas JZ, DiMarco JD, Lee FYF, Fairchild CR, Long BH, Vite GD (2002) SAR and pH Stability of Cyano-Substituted Epothilones. Org Lett 4: 3815
Sefkow M, Kiffe M, Schummer D, Höfle G (1998) Oxidative and Reductive Transformations of Epothilone A. Bioorg Med Chem Lett 8: 3025
Medina JC, Salomon M, Kyler KS (1988) A Mild Method for the Conversion of Alcohols to Methylthiomethyl Ethers. Tetrahedron Lett 29: 3773
Höfle G, Glaser N, Kiffe M, Hecht H-J, Sasse F, Reichenbach H (1999) N-Oxidation of Epothilone A-C and O-Acyl Rearrangement to C-19-and C21-Substituted Epothilones. Angew Chem Int Ed 38: 1971
Sefkow M, Kiffe M, Höfle G (1998) Derivatization of the C12-C13 Functional Groups of Epothilones A, B and C. Bioorg Med Chem Lett 8: 3031
Altmann K-H, Bold G, Caravatti G, End N, Flörsheimer A, Guagnano V, O’Reilly T, Wartmann M (2000) Epothilones and Their Analogs—Potential New Weapons in the Fight Against Cancer. Chimia 54: 612
Regueiro-Ren A, Borzilleri RM, Zheng X, Kim SH, Johnson JA, Fairchild CR, Lee FY, Long BH, Vite GD (2001) Synthesis and Biological Activity of Novel Epothilone Aziridines. Org Lett 3: 2693
Johnson J, Kim SH, Bifano M, DiMarco J, Fairchild C, Gougoutas J, Lee F, Long B, Tokarski J, Vite GD (2000) Synthesis, Structure Proof, and Biological Activity of Epothilone Cyclopropanes. Org Lett 2: 1537
Sefkow M, Höfle G (1998) Substitutions at the Thiazole Moiety of Epothilone. Heterocycles 48: 2485
Huisgen R, Kolbeck W (1965) N-Acyloxyammonium Salts. Tetrahedron Lett 6: 783
Höfle G, Glaser N, Leibold T, Karama U, Sasse F, Steinmetz H (2003) Semisynthesis and Degradation of the Tubulin Inhibitors Epothilone and Tubulysin. Pure Appl Chem 75: 167. See also: Glaser N (2001) Semisynthese Seitenketten-modifizierter Epothilone, Doctoral Thesis, Technical University of Braunschweig.
Borzilleri RM, Vite GD (2003) Epothilones: New Tubulin Polymerization Agents in Preclinical and Clinical Development. Drugs of the Future 27: 1149
Wartmann M, Loretan J, Reuter R, Hattenberger M, Muller M, Vaxelaire J, Maira S-M, Flörsheimer A, O’Reilly T, Nicolaou KC, Altmann K-H (2004) Preclinical Pharmacological Profile of ABJ879, a Novel Epothilone B Analog with Potent and Protracted Anti-tumor Activity. Proc Am Assoc Cancer Res 45: Abstract #5440
Höfle G, Glaser N, Leibold T, Sefkow M (1999) Epothilone A-D and Their Thiazolemodified Analogs as Novel Anticancer Agents. Pure Appl Chem 71: 2019
Karama U, Höfle G (2003) Synthesis of Epothilone 16,17-Alkyne Analogs by Replacement of the C13–C15(O)-Ring Segment of Natural Epothilone C. Eur J Org Chem: 1042
Dong SD, Sundermann K, Smith KMJ, Petryka J, Liu F, Myles DC (2004) Rapid Access to Epothilone Analogs via Semisynthetic Degradation and Reconstruction of Epothilone D. Tetrahedron Lett 45: 1945
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag/Wien
About this chapter
Cite this chapter
Altmann, KH. (2009). Semisynthetic Derivatives of Epothilones. In: The Epothilones: An Outstanding Family of Anti-Tumor Agents. Fortschritte der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products, vol 90. Springer, Vienna. https://doi.org/10.1007/978-3-211-78207-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-211-78207-1_4
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-78206-4
Online ISBN: 978-3-211-78207-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)